Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trials
CRO
One-third of data collected in trials may be unnecessary: study
Trials have been growing more complex, and the number of data points gathered in phase 3 trials grew from 929,203 to 3,560,201 between 2012 and 2020.
Darren Incorvaia
Sep 19, 2025 11:01am
ABPI releases life sci competition report as UK investment lags
Sep 10, 2025 5:30pm
IQVIA unveils AI suite for managing clinical trial finances
Sep 10, 2025 2:44pm
Australian biotech partners with Pi Health for cancer trial
Sep 4, 2025 8:30am
Servier hands Ideaya $210M upfront for ex-US rights to PKC asset
Sep 2, 2025 3:02pm
Flagship taps IQVIA as biotech support for company fleet
Aug 28, 2025 11:13am